Imagion Biosystems Statistics
Total Valuation
IBXXF has a market cap or net worth of 6.88 million. The enterprise value is 7.48 million.
| Market Cap | 6.88M |
| Enterprise Value | 7.48M |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 490.59M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +517.31% |
| Shares Change (QoQ) | +75.62% |
| Owned by Insiders (%) | 7.85% |
| Owned by Institutions (%) | 3.60% |
| Float | 386.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 141.33 |
| PB Ratio | -4.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.60 |
| EV / Sales | 145.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48
| Current Ratio | 0.48 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -90.55% |
| Return on Invested Capital (ROIC) | -400.94% |
| Return on Capital Employed (ROCE) | 162.44% |
| Weighted Average Cost of Capital (WACC) | 7.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.00% in the last 52 weeks. The beta is -0.16, so IBXXF's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | +30.00% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 44.42 |
| Average Volume (20 Days) | 54,967 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBXXF had revenue of 48,713 and -2.87 million in losses. Loss per share was -0.01.
| Revenue | 48,713 |
| Gross Profit | -1.35M |
| Operating Income | -2.34M |
| Pretax Income | -2.87M |
| Net Income | -2.87M |
| EBITDA | -2.34M |
| EBIT | -2.34M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.23 million in cash and 1.80 million in debt, with a net cash position of -563,516.
| Cash & Cash Equivalents | 1.23M |
| Total Debt | 1.80M |
| Net Cash | -563,516 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.44M |
| Book Value Per Share | -0.00 |
| Working Capital | -1.45M |
Cash Flow
| Operating Cash Flow | -2.70M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,808.76% |
| Pretax Margin | -5,900.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IBXXF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -517.31% |
| Shareholder Yield | -517.31% |
| Earnings Yield | -41.75% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 16, 2023. It was a reverse split with a ratio of 0.025.
| Last Split Date | Nov 16, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
IBXXF has an Altman Z-Score of -54.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -54.92 |
| Piotroski F-Score | 2 |